Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 05 - 12 save search
Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results
Published: 2021-05-12 (Crawled : 21:00) - globenewswire.com
VIR | $7.96 -3.52% -3.64% 880K
|
Health Technology
|
| O: 0.89%
H: 4.18%
C: 0.23%
GBIO | $2.775 -6.88% -7.39% 200K
|
Health Technology
|
| O: 2.48%
H: 2.42%
C: -1.31%
financial results potential gene therapy therapy results gene therapies preclinical pre-clinical
Journal of Clinical Oncology Publishes Clinical Data for Cohort 2 in Iovance C-144-01 Study of Lifileucel TIL Therapy in Metastatic Melanoma
Published: 2021-05-12 (Crawled : 21:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 1.0%
H: 3.91%
C: -5.05%
therapy xin
Frontiers in Cancer Immunotherapy Conference
Published: 2021-05-12 (Crawled : 18:00) - cuebiopharma.com
CUE | $1.6 -1.84% -1.87% 170K
|
Health Technology
|
| O: -1.07%
H: 7.22%
C: 1.45%
immunotherapy therapy cancer conference
BioCryst Receives UK Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
Published: 2021-05-12 (Crawled : 16:00) - globenewswire.com
BCRX | $4.49 -1.97% -2.0% 3M
|
Health Technology
|
| O: -1.98%
H: 6.47%
C: 4.96%
therapy approval hereditary angioedema
Vertex and CRISPR Therapeutics to Present New Clinical Data on Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ For Severe Hemoglobinopathies at the Annual European Hematology Association Virtual Congress
Published: 2021-05-12 (Crawled : 15:15) - globenewswire.com
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: -0.44%
H: 1.7%
C: 0.29%
CRSP M | $56.14 1.04% 1.03% 1.7M
|
Health Technology
|
| O: -2.06%
H: 2.89%
C: -0.56%
crispr europe therapy ctx001
BioMarin Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting
Published: 2021-05-12 (Crawled : 13:00) - biospace.com/
BMRN S | $90.08 -0.43% -0.43% 940K
|
Health Technology
|
| O: -0.55%
H: 1.57%
C: 0.44%
presentation therapy
GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates
Published: 2021-05-12 (Crawled : 13:00) - biospace.com/
GTBP | $3.97 1.3% 1K
|
Manufacturing
|
| O: -0.4%
H: 1.93%
C: -14.03%
phase 2 biopharma therapy trial solid tumors
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
Published: 2021-05-12 (Crawled : 13:00) - biospace.com/
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 0.81%
H: 6.67%
C: 1.33%
presentation treatment blood therapy hiv
Advanced Therapy Medicinal Products Market Size Worth $21.2 Billion By 2028: Grand View Research, Inc.
Published: 2021-05-12 (Crawled : 08:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: -0.44%
VCEL | $43.86 -5.19% -5.47% 430K
|
Health Technology
|
| O: -4.6%
H: 4.8%
C: -1.06%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.44%
H: 1.27%
C: -1.14%
therapy research
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.